Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page

NIDA's 25th Anniversary Symposium

Scientific Symposium and Evening Event for the Public

Poster Presenter Biographies

Frederick L. Altice, M.D.
Associate Professor of Medicine
Community Health Care Van and HIV in Prisons Program
Yale University AIDS Program
Suite 323
135 College Street
New Haven, CT 06510-2483
(203) 737-2883
(203) 737-5143 Fax and

Dr. Altice is an associate professor at the Yale University AIDS Program and is the director of both the Community Health Care Van and the HIV in Prisons Program. He has been involved in establishing several innovative health delivery programs for drug users with and at risk for HIV infection. His research interests include evaluation of health and risk reduction interventions for drug users, adherence with antiretroviral therapy, health services and health outcomes research, and clinical epidemiology.

Dr. Altice has focused his research efforts primarily on the health status of out-of-treatment injection drug users. This work has primarily been conducted in correctional inmate and needle exchange settings. He has conducted longitudinal cohort studies of risk behavior and the interface between behavioral and biomedical factors associated with HIV risk and health status and is currently exploring health services research among active drug users with co-morbid medical and psychiatric conditions. This exploratory work will be used for development of further interventions to improve the health status of drug users.

Leslie Amass, Ph.D.
Vine Street Center
Adjunct Assistant Professor
Department of Psychology
University of Colorado at Denver
Assistant Professor
Department of Psychiatry
University of Colorado School of Medicine
1741 Vine Street
Denver, CO 80206
(303) 315-8463
(303) 388-3218 Fax

Dr. Amass is an assistant professor of psychiatry at the University of Colorado School of Medicine, adjunct assistant professor of psychology at the University of Colorado at Denver, and the director of Vine Street Center, an outpatient licensed Narcotic Treatment Program in Denver. She is also a certified addictions counselor in the State of Colorado and expects licensure as a clinical psychologist in Colorado this fall.

Dr. Amass received her B.S. degree in psychobiology in 1983 from the University of California, Los Angeles. She received both M.A. (1985) and Ph.D. (1990) degrees in experimental/physiological psychology from Boston University. Dr. Amass has substantial expertise and a broad background in the research and treatment of substance dependence. She is especially well known for her expertise in the pharmacological management of opioid dependence and for being at the forefront of thinking about technology transfer of empirically validated behavioral treatments to community treatment settings.

Dr. Amass is the principal investigator of a NIDA R01 to study the buprenorphine-naloxone tablet and explore novel uses of this medication for opioid dependence treatment. In addition, she recently received another R01 from NIDA to study novel strategies for transferring contingency management therapies into community drug treatment settings.

Dr. Amass serves on the advisory boards for buprenorphine and buprenorphine-naloxone in both the United States and Canada and was a key speaker at NIDA's Stage III Behavioral Therapy Research Meeting. The Vine Street Center is one of the only clinics in the country providing buprenorphine, methadone, LAAM, and naltrexone treatment for opioid dependence under one roof and serves as an excellent model for the integration of research and clinical programming in a "real-life" setting. Dr. Amass is the author or coauthor of more than 68 scientific reports, review articles, and monographs.

Julia H. Arnsten, M.D., M.P.H.
Assistant Professor
Department of Medicine and Department of Epidemiology and Social Medicine
Montefiore Medical Center
111 East 210th Street
Bronx, NY 10467
(718) 920-4571
(718) 231-8655 Fax

Dr. Arnsten graduated from the New York University School of Medicine in 1990 and completed residency training in Primary Care Internal Medicine at NYU Medical Center/Bellevue Hospital Center in 1993. Following residency, she was a fellow in the General Internal Medicine Program at Harvard Medical School and Massachusetts General Hospital. Before joining the faculty at Montefiore Medical Center and Albert Einstein College of Medicine, she was an instructor at Harvard Medical School and a staff physician at Massachusetts General Hospital, working with the Boston Health Care for the Homeless program. At Montefiore, Dr. Arnsten is an assistant professor in both the Department of Medicine and the Department of Epidemiology and Social Medicine. Her major research interests are epidemiology of HIV/AIDS and adherence with medication taking.

Dr. Arnsten is a Robert Wood Johnson Generalist Physician Faculty Scholar and the principal investigator of a NIDA grant examining adherence with antiretroviral therapy and viral resistance among HIV-infected drug users.

Thomas H. Brandon, Ph.D.
Associate Professor
Department of Psychology
University of South Florida
Tobacco Research and Intervention Program
H. Lee Moffitt Cancer Center and Research Institute
4115 East Fowler Avenue
Tampa, FL 33617
(813) 632-1750
(813) 632-1755 Fax

Dr. Brandon is associate professor of psychology at the University of South Florida and director of the Tobacco Research and Intervention Program at the H. Lee Moffitt Cancer Center and Research Institute in Tampa. He received his master's degree and doctorate in clinical psychology from the University of Wisconsin-Madison. He held assistant and associate professor positions at the State University of New York for 7 years before moving to the University of South Florida in 1997.

Dr. Brandon conducts basic human behavioral research on factors that influence the maintenance and cessation of smoking (e.g., mood management, conditioned responding, outcome expectancies) as well as applied research in which those factors are targeted in smoking cessation interventions. Lately he has also been developing cost-effective minimal interventions designed to reduce the rate of smoking relapse. Dr. Brandon was recently appointed editor of the peer-reviewed journal Psychology of Addictive Behaviors for a 5-year term beginning in 1999. Research in his laboratory has been funded by the National Institute on Drug Abuse, the National Cancer Institute, the American Cancer Society, the American Heart Association, and the American Lung Association.

Michael Gary Byas-Smith, M.D.
Assistant Professor
Department of Anesthesiology
Emory University Hospital
Emory University School of Medicine
3rd Floor, B Wing
1364 Clifton Road, N.E.
Atlanta, GA 30322
(404) 778-5872
(404) 778-5194 Fax

Dr. Byas-Smith received his bachelor's degree in biology from Morehouse College in 1983 and his medical degree from the University of Illinois School of Medicine in 1987. He served his residency at Emory University School of Medicine in 1988-91 in anesthesiology. Dr. Byas-Smith had a fellowship at the National Institutes of Health from 1991 to 1993. During the same period, he was a clinical instructor in the Department of Anesthesiology at the University of Maryland, Baltimore, Maryland. Since 1993 he has been an assistant professor of anesthesiology at Emory University School of Medicine. He is a member of the American Society of Anesthesiologists, American Pain Society, International Association for the Study of Pain, American Society of Regional Anesthesia, Georgia Society of Anesthesiologists, Society for Neuroscience, and American Medical Association.

Linda Chang, M.D.
Associate Professor
Department of Neurology
School of Medicine
University of California, Los Angeles
Room B-4
Harbor UCLA Medical Center
1000 West Carson Street
Torrance, CA 90509
(310) 222-3890
(310) 618-1273 Fax

Dr. Chang completed her medical degree at Georgetown University and her neurology residency at UCLA. She is currently an associate professor in neurology at UCLA School of Medicine and Harbor-UCLA Medical Center. She is the recipient of a Mentored Scientist Development Award for Clinicians (K-20, year 5) from NIDA and is the principal investigator on two independent research projects (R01 from NIDA and from NINDS), as well as a co-investigator on several other NIH-funded studies. Her major research interests are the neurological involvement of HIV and drug abuse. She has worked extensively in the application of neuroimaging techniques to the evaluation of brain diseases, especially in the application of MR techniques to neuro-AIDS and to drug abuse. Her work has resulted in more than 50 peer-reviewed papers, 8 chapters, and more than 80 abstracts. She is an active member of the American Academy of Neurology, American Medical Association, International Society of Magnetic Resonance in Medicine, Los Angeles Neurological Society, American Association of Electrodiagnostic Medicine, California Association of Neurologists, and the College on Problems of Drug Dependence. She is also a reviewer for numerous scientific journals and has participated in various grant reviews at the NIH.

Howard D. Chilcoat, Sc.D.
Research Scientist
Henry Ford Health Science Center
Detroit, MI 48202
(313) 876-9963
(313) 874-6221 Fax

Dr. Chilcoat is a psychiatric epidemiologist with a specific interest in the epidemiology of drug use and drug-related problems. He is currently a research scientist at the Henry Ford Health Sciences Center in Detroit. He was an NIMH predoctoral fellow in psychiatric epidemiology at the Johns Hopkins University School of Hygiene and Public Health. Prior to his tenure at Henry Ford Health Sciences Center in 1995, he was a staff fellow in the NIDA Division of Intramural Research. Currently, his NIDA-funded research investigates the roles of interactions between individual susceptibility and social environmental factors in the development of drug initiation in childhood and transitions to later stages of drug use through adolescence. Research funded by NIMH studies the nosology of PTSD.

Monique Ernst, M.D., Ph.D.
Associate Director
Brain Imaging Center
Division of Intramural Research
National Institute on Drug Abuse
National Institutes of Health
5500 Nathan Shock Drive
Baltimore, MD 21224
(410) 550-1518
(410) 550-1441 Fax

Dr. Ernst is the associate director of the Brain Imaging Center at the National Institute on Drug Abuse, National Institutes of Health. She is board certified in general psychiatry and in child and adolescent psychiatry, and has a doctorate in neurophysiology. She has conducted a number of PET protocols at NIMH and NIDA, including studies of neuropsychiatric disorders (ADHD, Tourette's disorders, autism, Lesch-Nyhan disease), cognitive effects of nicotine, and, currently, predictors of substance abuse in adolescents. Her area of expertise includes psychopharmacology and neuropsychiatric disorders.

William Brooks Gentry, M.D.
Assistant Professor
Department of Anesthesiology, Pharmacology, and Toxicology
College of Medicine
University of Arkansas for Medical Sciences
Slot 515
4301 West Markham Street
Little Rock, AR 72205
(501) 686-7611
(501) 603-1951 Fax

Dr. Gentry is an assistant professor of anesthesiology and pharmacology and toxicology at the University of Arkansas for Medical Sciences in Little Rock, Arkansas. After his anesthesiology residency at Northwestern University in Chicago, he completed a postdoctoral fellowship in clinical pharmacology/pharmacokinetics at Northwestern University. He has collaborated with Dr. Michael Owens at the University of Arkansas since 1995 on two NIDA-funded studies, "Immunotherapy for Drug Abuse" and "Antibody-based Therapy for Methamphetamine Abuse." He currently has a K08 award from NIDA entitled "Mechanisms of Onset and Offset of Rapid Stimulant Effects."

Randy L. Gollub, M.D., Ph.D.
Assistant Professor
Harvard Medical School
Assistant Director of Psychiatric Neuroimaging
Department of Psychiatry
Massachusetts General Hospital
Building 149, Room 9109
13th Street
Charlestown, MA 02129
(617) 724-9602
(617) 726-4078 Fax

Dr. Gollub obtained her bachelor's degree in neurobiology from Northwestern University (1980) and her medical and doctoral degrees in neuropharmacology from Duke University Medical Center (1987) and completed her psychiatry residency and fellowship training in electrophysiology at Yale University School of Medicine (1993). Her first (and current) faculty position, granted by the chair of the Consolidated Department of Psychiatry at Harvard Medical School, Joseph Coyle, is in the Department of Psychiatry at Massachusetts General Hospital and includes teaching second-year Harvard Medical School students (human nervous system and behavior) and Massachusetts General Hospital/McLean psychiatry residents (Acute Psychiatry Service in the Emergency Department).

Her current research interests focus on the use of functional magnetic resonance imaging (fMRI) to study the fundamental neurobiological processes underlying normal and pathological human brain activity. Several ongoing projects include:

  • Neurobiology of substance abuse (with Bruce Rosen and Hans Breiter primarily and many others importantly). She has been studying how drugs of abuse act in the brain to produce states of euphoria and drug craving in subjects who are cocaine dependent.

  • Neurobiology of working memory (WM) in normal subjects as compared with schizophrenia subjects. Studies include an evaluation of test-retest reliability and a study of the effects of antipsychotic medication on WM performance and fMRI activation in the dorsolateral prefrontal cortex in schizophrenia subjects (with Dara Manoach, Don Goff, Scott Rauch, and Stephan Heckers).

  • Effects of acute cocaine administration on WM performance and fMRI activation in co-morbid cocaine-abusing schizophrenia subjects (with Dara Manoach, Don Goff, Scott Rauch, and Roy Perlis).

  • New initiative on the neurobiology of acupuncture analgesia (with Kathleen Hui, Mark Dershwitz, Patrick Aquino, and Ken Kwong).

  • Development of improved methods for fMRI data analysis including investigation of the effects of physiologic changes on fMRI signals in the brain and on the stability and reliability of fMRI data sets.

Grant Support: NIDA K21 DA00275-01, Functional brain mapping of opiate/noradrenergic interactions (Randy L. Gollub, P.I.); NIDA PO1 DA 09467, Functional mapping of cocaine activation, craving and withdrawal (Bruce Rosen, P.I.), and NIDA DA11229-01 FMRI of cocaine effects in cocaine abusing schizophrenics (Randy L. Gollub, P.I., Dara Manoach, Co-Investigator).

Denise Hallfors, Ph.D.
Research Associate Professor
Department of Maternal and Child Health
School of Public Health
University of North Carolina at Chapel Hill
Rosenau Hall, CB #7400
Chapel Hill, NC 27599-7400
(919) 966-6287
(919) 966-0458 Fax

Dr. Hallfors is currently research associate professor in the School of Public Health, Maternal and Child Health Department, University of North Carolina, Chapel Hill. She is the principal investigator of two large studies: a meta-analysis of school surveys to assess effectiveness of community prevention programs, funded as a FIRST Award by the National Institute on Drug Abuse, and a diffusion study, funded by the Robert Wood Johnson Foundation, focusing on the new Department of Education policy requiring Safe and Drug Free Schools grantees to adopt the "Principles of Effectiveness." Dr. Hallfors is also co-principal investigator in the evaluation of Fighting Back, a national demonstration supporting community substance abuse prevention programs, funded by the Robert Wood Johnson Foundation. She is a nurse and earned her doctoral degree from the Heller Graduate School at Brandeis University, where she was a National Institute of Mental Health fellow in health services research. Dr. Hallfors teaches a core graduate course in program planning and evaluation and is a member of the board of directors of the Society for Prevention Research.

Carl R. Lupica, Ph.D.
Research Fellow
Cellular Neurobiology Branch
Intramural Research Program
National Institute on Drug Abuse
National Institutes of Health
Building C, Room 267
5500 Nathan Shock Drive
Baltimore, MD 21224
(410) 550-2712
(410) 550-3079 Fax

Dr. Lupica received his bachelor's degree in zoology and psychology from Ohio University in 1983. He then received M.A. and Ph.D. degrees in psychobiology and neuroscience from Wayne State University in 1989. Dr. Lupica completed a NIDA-funded postdoctoral fellowship at the University of Colorado Health Sciences Center in 1991. He then became an assistant professor of pharmacology at the University of Colorado in 1993, where he received extramural grant support from NIDA. Dr. Lupica has been with the Intramural Research Program at NIDA since October 1998.

Catherine A. Martin, M.D.
Child Psychiatrist
Department of Psychiatry
Kentucky Clinic
University of Kentucky College of Medicine
Wing B
820 South Limestone Street
Lexington, KY 40536-0284
(606) 323-6021, ext. 231
(606) 323-1670 Fax

Dr. Martin is a child psychiatrist in the Department of Psychiatry at the University of Kentucky College of Medicine. She is a medical educator and a clinician with a special interest in impulse disorders. She received a NIDA K08 award in 1998 to expand her research expertise in the area of impulsivity, puberty, and drug abuse. She is also participating in a NIDA grant investigating how drug effects are influenced by sex steroids in women and a NIDA grant implementing a drug abuse science curriculum to educate female junior high school students about drug abuse and encourage their entry into the sciences.

Michael A. Mathier, M.D.
Medical Director
Heart Failure Transplant Office
Allegheny General Hospital
Assistant Professor of Medicine
Allegheny University of the Health Sciences
4th Floor Snyder Pavilion
320 East North Avenue
Pittsburgh, PA 15217
(412) 359-3131
(412) 359-4817 Fax

Dr. Mathier graduated summa cum laude from the University of Pennsylvania in 1986 with a B.A. degree in natural sciences and from the College of Physicians and Surgeons of Columbia University in 1990. He completed internal medicine and cardiology training at Massachusetts General Hospital in 1997. Within this period he completed a year of clinical heart failure and cardiac transplantation training and 2 years of large- and small-animal physiology research focusing on heart failure and toxic cardiomyopathies. He has been the medical director of the Heart Failure Service and assistant professor of medicine at Allegheny General Hospital in Pittsburgh, Pennsylvania, since 1997. He was recently awarded a K08 award from NIDA for ongoing studies of the effects of cocaine in altered cardiovascular substrates.

Lisa Metsch, Ph.D.
Assistant Professor
Department of Epidemiology and Public Health
Associate Director
Comprehensive Drug Research Center
University of Miami School of Medicine
Suite 1108
1400 N.W. 10th Avenue
Miami, FL 33136
(305) 243-3471
(305) 243-3353 Fax

Dr. Metsch is an assistant professor in the University of Miami School of Medicine's Department of Epidemiology and Public Health. She also serves as associate director at the Comprehensive Drug Research Center. Currently, Dr. Metsch is the recipient of a Mentored Research Scientist Development Award (K01) from the National Institute on Drug Abuse. The research focus of this career award is to develop intervention strategies to address primary and secondary prevention needs of HIV-infected drug users. Dr. Metsch is also principal investigator on a grant from the Substance Abuse Policy Research Program of the Robert Wood Johnson Foundation to study the role of drug treatment in facilitating the transitions from welfare to work among women who use drugs. Dr. Metsch currently serves as a reviewer for the HIV prevention committee (ARR7) for the National Institutes of Health and also reviews grant applications for the Robert Wood Johnson Foundation and the Substance Abuse and Mental Health Services Administration. She maintains an active publication record and has presented at numerous national and international conferences. For her academic accomplishments, Dr. Metsch received the 1999 Junior Faculty Clinical Research Award from the University of Miami School of Medicine.

Eric Moolchan, M.D. Senior Scientist
Intramural Research Program
National Institute on Drug Abuse
National Institutes of Health
P.O. Box 5180
5500 Nathan Shock Drive
Baltimore, MD 21224
(410) 550-1846
(410) 550-2971 Fax

Dr. Moolchan directs the Teen Tobacco Addiction Treatment Research Clinic (TTATRC), Clinical Pharmacology and Therapeutics Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland. In this role, he develops and oversees research protocols with a primary focus on treatment of tobacco dependence and related issues. Dr. Moolchan is the principal investigator for a controlled pilot study of the nicotine patch and gum combined with counseling in adolescent smokers ("Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Tobacco-Dependent Adolescents"). His other research interests include therapeutic drug monitoring (in opioid and cocaine dependence) and cocaine kinetics.

Yavin Shaham, Ph.D.
Behavioral Neuroscience Branch
Intramural Research Program
National Institute on Drug Abuse
National Institutes of Health
5500 Nathan Shock Drive
Baltimore, MD 21224
(410) 550-1746
(410) 550-1612 Fax

Dr. Shaham received a B.Sc. degree in biology and psychology (1986) and an M.A. degree in psychology (1988) from the Hebrew University, Jerusalem, Israel. He then obtained a doctorate in psychology (1992) from the Uniformed Services University of the Health Sciences in Bethesda, Maryland. His postdoctorate training (1992-95) was conducted at the laboratory of Dr. Jane Stewart, Concordia University, Montreal. He then held a research position at the Addiction Research Foundation, Toronto, and was an assistant professor at the Psychology Department, University of Toronto. Dr. Shaham joined the Behavioral Neuroscience branch, NIDA/IRP, in 1998. The major topic of study in his laboratory is the neurobiology of relapse to drug use.

Mark E. von Zastrow, M.D., Ph.D.
Associate Professor
Departments of Psychiatry and Cellular and Molecular Pharmacology
Program in Cell Biology
University of California, San Francisco
Box 0984F
401 Parnassus Avenue
San Francisco, CA 94143-0984
(415) 476-7855
(415) 476-7884 Fax

Dr. von Zastrow has been an associate professor of psychiatry and pharmacology at the University of California, San Francisco, since 1998. He earned his bachelor's degree in biochemistry at Cornell University in 1980 and his doctorate in cell biology and his medical degree at Yale University in 1987. Among the awards he has received are the Cell Sciences Imaging Facility Research Award, Program in Molecular and Genetic Medicine, Stanford University School of Medicine; the Scientist Development Award (K21), National Institute on Drug Abuse; and the Presidential Early Career Award for Scientists and Engineers, United States Office of Science and Technology.

Shaomeng Wang, M.D.
Assistant Professor
Departments of Oncology and Neuroscience
Institute for Cognitive and Computational Sciences
Georgetown University Medical Center
The Research Building, Room EP 07
3970 Reservoir Road
Washington, DC 20007-2197
(202) 687-2028
(202) 687-0617 Fax

Dr. Wang received his doctorate from Case Western Reserve University in 1992 in computational chemistry and drug design. He did his postdoctoral training at the National Cancer Institute, National Institutes of Health, in the area of drug design and molecular modeling. In 1996, he joined the Georgetown University Medical Center as an assistant professor in the Departments of Oncology and Neuroscience, and as senior investigator at the Lombardi Cancer Center and Georgetown Institute for Cognitive and Computational Sciences (neuroscience). Over the years, he has worked on the design and discovery of drugs in drug abuse, cancer, infectious diseases, and immunology. Dr. Wang not only has extensive expertise in developing new methods for computer-aided drug design, computational chemistry, and biology but also has rich experience in practical drug design and discovery problems. He has published more than 60 papers in the last 8 years in the areas of molecular modeling; computer-aided, structure-based drug design; 3D-database pharmacophore searching for drug discovery; computational chemistry; and biology. He holds several international patents.

[25th Anniversary Symposium Index][25th Anniversary Agenda][25th Anniversary Poster Abstracts]

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal